The FDA has labeled a Texas bakery’s recall of over 700 cases of brioche bread products as a Class II risk due to the presence of undeclared allergens and artificial dye. The products were found to contain milk, soy, and FD&C Yellow No. 5, which can potentially cause allergic reactions in those with sensitivities. Reactions to these allergens can range from hives and rashes to more severe symptoms such as anaphylaxis. The Bakery Group, the manufacturer of the products, disclosed that the labeling omissions were due to human error in the packaging and labeling department.
The Bakery Group’s recall includes 629 cases of Dense Brioche Pullman Loaf and 104 cases of 4.5-inch Brioche Hamburger Buns. These products were distributed to wholesalers in Texas between December 24, 2024, and March 12, 2025. The affected products were packaged in brown boxes labeled for Ben E. Keith or Rodeo Goat Casa Linda, with specific product codes for identification. The company has assured that corrective actions were taken as of March 19 to address the labeling error and avoid similar issues in the future. There have been no reported illnesses linked to the consumption of these products.
The presence of milk and soy in the brioche bread products poses a risk to individuals with allergies or sensitivities to these ingredients. In addition, the synthetic dye Yellow No. 5, also known as tartrazine, can trigger allergic responses, particularly in those with aspirin sensitivity. The FDA emphasized the potential serious allergic reactions that could occur if these allergens are consumed by sensitive individuals. Customers who have purchased the recalled products are advised to avoid consuming them and can contact The Bakery Group for further information and assistance.
The FDA’s classification of the recall as Class II indicates that while the affected products may cause temporary or medically reversible adverse health consequences, the risk of severe harm is low. The agency’s announcement of the recall serves to alert consumers, wholesalers, and distributors to the potential allergen contamination in the brioche bread products. The Bakery Group expressed regret for the labeling oversight and apologized for any inconvenience caused to its distributors and customers. The company has committed to addressing the issue promptly and ensuring that corrective measures are implemented to prevent similar incidents.
The Bakery Group’s recall highlights the importance of accurate labeling and transparency in food allergen disclosures. Properly identifying and labeling allergens in food products is crucial to protecting individuals with allergies and sensitivities from harmful reactions. The company’s cooperation with the FDA and prompt corrective actions demonstrate a commitment to food safety and consumer well-being. Customers who have purchased the recalled brioche bread products are urged to check the packaging for the specific product codes and contact the manufacturer for guidance on how to handle the affected items. Ongoing communication and vigilance are essential to managing food recalls and protecting public health.
